DK0920865T3 - Farmaceutiske sammensætninger indeholdende norastemizol - Google Patents

Farmaceutiske sammensætninger indeholdende norastemizol

Info

Publication number
DK0920865T3
DK0920865T3 DK99200247T DK99200247T DK0920865T3 DK 0920865 T3 DK0920865 T3 DK 0920865T3 DK 99200247 T DK99200247 T DK 99200247T DK 99200247 T DK99200247 T DK 99200247T DK 0920865 T3 DK0920865 T3 DK 0920865T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
compositions containing
compound
formula
treatment
Prior art date
Application number
DK99200247T
Other languages
Danish (da)
English (en)
Inventor
Raymond L Woosley
A K Gunnar Aberg
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of DK0920865T3 publication Critical patent/DK0920865T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK99200247T 1992-09-03 1993-09-03 Farmaceutiske sammensætninger indeholdende norastemizol DK0920865T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94005492A 1992-09-03 1992-09-03

Publications (1)

Publication Number Publication Date
DK0920865T3 true DK0920865T3 (da) 2004-04-19

Family

ID=25474141

Family Applications (2)

Application Number Title Priority Date Filing Date
DK93921359T DK0658110T3 (da) 1992-09-03 1993-09-03 Anvendelse af norastemizol til behandling af allergisk rhinitis
DK99200247T DK0920865T3 (da) 1992-09-03 1993-09-03 Farmaceutiske sammensætninger indeholdende norastemizol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK93921359T DK0658110T3 (da) 1992-09-03 1993-09-03 Anvendelse af norastemizol til behandling af allergisk rhinitis

Country Status (13)

Country Link
US (5) US6130233A (de)
EP (3) EP0658110B1 (de)
JP (3) JPH08501083A (de)
AT (2) ATE187642T1 (de)
AU (1) AU687746B2 (de)
CA (1) CA2143610C (de)
DE (3) DE69333387T2 (de)
DK (2) DK0658110T3 (de)
ES (2) ES2210957T3 (de)
GB (1) GB2285219B (de)
GR (1) GR3032541T3 (de)
PT (2) PT920865E (de)
WO (1) WO1994007495A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
EP1035869A1 (de) * 1997-03-26 2000-09-20 Sepracor, Inc. Chemisch und thermisch stabile norastemizol formulierungen
US6248308B1 (en) * 1998-04-14 2001-06-19 Sepracor Inc. Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma
CA2450583A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
US6627646B2 (en) 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
EP2266590A3 (de) 2002-02-22 2011-04-20 Shire LLC Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
US20080306116A1 (en) * 2007-06-08 2008-12-11 Christ Andreas D Aryloxazole, aryloxadiazole and benzimidazole derivatives
EP2240018B1 (de) 2008-01-04 2016-05-25 Schabar Research Associates LLC Zusammensetzung enthaltend ein analgetikum und ein antihistaminikum
EP2106784B1 (de) * 2008-04-03 2015-04-22 Rohm and Haas Company Haarstylingzusammensetzung
IL299845A (en) 2020-07-15 2023-03-01 Schabar Res Associates Llc Oral unit dose compounds consisting of ibuprofen and famotidine for the treatment of acute pain and to reduce the severity and/or risk of heartburn
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
EP0144101B1 (de) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bizyklisches Heterozyklyl aufveisende N-(bizyklisches Heterozyklyl-4-piperidinamine
US4835161A (en) * 1986-02-03 1989-05-30 Janssen Pharmaceutica N.V. Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
EG17993A (en) * 1986-02-03 1991-08-30 Janssen Pharmaceutica Nv Anti-histaminic compositions containing n-heterocyclyl-4-piperidinanines
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
DK1041990T3 (da) 1997-12-23 2006-10-02 Schering Corp Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin

Also Published As

Publication number Publication date
AU687746B2 (en) 1998-03-05
CA2143610A1 (en) 1994-04-14
ES2210957T3 (es) 2004-07-01
ES2139673T3 (es) 2000-02-16
GB2285219B (en) 1996-09-11
DE69327328D1 (de) 2000-01-20
EP0658110A1 (de) 1995-06-21
EP0658110B1 (de) 1999-12-15
US6130233A (en) 2000-10-10
EP1262183A1 (de) 2002-12-04
DK0658110T3 (da) 2000-04-17
DE69333387D1 (de) 2004-02-19
EP0920865B1 (de) 2004-01-14
GB2285219A (en) 1995-07-05
GR3032541T3 (en) 2000-05-31
PT658110E (pt) 2000-06-30
US6187795B1 (en) 2001-02-13
GB9504329D0 (en) 1995-04-26
JP2002308772A (ja) 2002-10-23
WO1994007495A1 (en) 1994-04-14
JP2002255817A (ja) 2002-09-11
AU4848093A (en) 1994-04-26
US6124320A (en) 2000-09-26
EP0920865A1 (de) 1999-06-09
DE69333387T2 (de) 2004-12-09
ATE187642T1 (de) 2000-01-15
US6187794B1 (en) 2001-02-13
DE4394931T1 (de) 1995-07-20
CA2143610C (en) 2004-08-24
US6268382B1 (en) 2001-07-31
DE69327328T2 (de) 2000-06-21
JPH08501083A (ja) 1996-02-06
ATE257704T1 (de) 2004-01-15
PT920865E (pt) 2004-06-30

Similar Documents

Publication Publication Date Title
DK0920865T3 (da) Farmaceutiske sammensætninger indeholdende norastemizol
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
SE9901573D0 (sv) New compounds
TR200101633T2 (tr) Farmasötik bileşim
SE9901572D0 (sv) New compounds
DK347289D0 (da) Terapeutiske forbindelser
DE60233578D1 (de) Phosphorenthaltende Verbindugnen mit antithrombitische Wirkung
KR890001555A (ko) 요산 배설용 조성물